AAV mediated gene therapy as local treatment modality directed against amyloid beta oligomers in the brain using a high affinity, high specificity antibody
Bas Blits(Tilburg University), Guus A.P.H. Scheefhals(Tilburg University), August B. Smit(Vrije Universiteit Amsterdam), Hans Preusting(Tilburg University), Rolinka van der Loo(Amsterdam Neuroscience), Titia Gebuis(Amsterdam Neuroscience), Yvonne Gouwenberg(Vrije Universiteit Amsterdam), Ronald E. van Kesteren(Amsterdam Neuroscience)
Cited by 0
Related Papers
Synapse formation between central neurons requires postsynaptic expression of the MEN1 tumor suppressor gene.
|PubMed|2001|469
Phenotypic Characterization of Retinoic Acid Differentiated SH-SY5Y Cells by Transcriptional Profiling
|PLoS ONE|2013|252
Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer’s disease
|Molecular Psychiatry|2019|225
The Netherlands Twin Register Biobank: A Resource for Genetic Epidemiological Studies
|Twin Research and Human Genetics|2010|206